APA (7th ed.) Citation

V, P., RL, C., RN, E., M, F., BJ, M., & BM, S. (2025). Checkpoint inhibitor rechallenge in advanced endometrial cancer: Revisiting the immune landscape beyond first-line therapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 35(11), 102124. https://doi.org/10.1016/j.ijgc.2025.102124

Chicago Style (17th ed.) Citation

V, Podder, Coleman RL, Eskander RN, Flint M, Monk BJ, and Slomovitz BM. "Checkpoint Inhibitor Rechallenge in Advanced Endometrial Cancer: Revisiting the Immune Landscape Beyond First-line Therapy." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 35, no. 11 (2025): 102124. https://doi.org/10.1016/j.ijgc.2025.102124.

MLA (9th ed.) Citation

V, Podder, et al. "Checkpoint Inhibitor Rechallenge in Advanced Endometrial Cancer: Revisiting the Immune Landscape Beyond First-line Therapy." International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 35, no. 11, 2025, p. 102124, https://doi.org/10.1016/j.ijgc.2025.102124.